• Phosphatase Inhibitor Cocktail 1 Workflow

  2026-09-07

  Protect labile phosphorylation states from cell harvest through Western blotting, co-immunoprecipitation, and phosphoproteomic analysis. This workflow combines a practical 1X starting condition with tissue-panel guidance inspired by UPF3A expression research, while highlighting controls and troubleshooting limits.

• Pifithrin-α: Practical p53 Inhibition Workflows

  2026-09-07

  Pifithrin-α provides a reversible way to test whether DNA damage, deltamethrin stress, ferroptosis, or irradiation phenotypes depend on p53 signaling. This guide translates a recent maternal neurotoxicity study into practical cell-based workflows, formulation advice, controls, and troubleshooting strategies.

• EdU Imaging Kits: Reading S-Phase in RCC

  2026-09-05

  EdU Imaging Kits (HF488) provide a precise way to interpret DNA synthesis in renal cell carcinoma models. This article connects EdU click chemistry with the esculin RCC study and offers a practical framework for microscopy, flow cytometry, and orthogonal validation.

• PPT and ERα: From Selective Signal to Translation

  2026-09-05

  PPT (Propyl Pyrazole Triol) provides a precise way to perturb ERα while minimizing ERβ-driven ambiguity. This thought-leadership article connects its receptor-level pharmacology with the FOXM1–ERα network reported in female lung adenocarcinoma and offers a practical framework for translational validation.

• Cyclic di-GMP: From Signal to Assay Design

  2026-09-04

  Cyclic di-GMP is an intracellular second messenger linking bacterial persistence biology with STING-centered immune modulation research. This article focuses on stage-resolved assay design, causal interpretation, and the practical limits of translating bacterial findings into cancer immunotherapy studies.

• Z-VEID-FMK: Caspase-6 Inhibitor Workflow

  2026-09-04

  Z-VEID-FMK is a cell-permeable, irreversible caspase-6 inhibitor for separating caspase-6-dependent proteolysis from broader apoptotic effects. This workflow connects practical apoptosis assays with a viral immune-evasion model involving PRRSV N-protein cleavage, while emphasizing controls, timing, and interpretation.

• V5 Epitope Tag Peptide: Workflow Guide

  2026-09-03

  Build more reliable recombinant-protein detection workflows with the V5 Epitope Tag Peptide as a sequence-specific competition control, assay calibrator, and purification aid. The guide connects routine Western blotting and immunoprecipitation with antibody-kinetic insights from single-molecule microscopy, while emphasizing practical controls and troubleshooting.

• Dual Luciferase Reporter Gene System for BMSC Studies

  2026-09-02

  Apply the Dual Luciferase Reporter Gene System to separate pathway-dependent transcriptional effects from sample-to-sample variability in BMSC research. This workflow combines firefly/Renilla normalization, no-lysis mammalian cell detection, and practical controls for studying MRF–FSHR–cAMP-PKA-CREB regulation.

• SAR131675: A VEGFR-3 Assay Strategy

  2026-09-02

  Explore SAR131675, a selective VEGFR-3 inhibitor, through a practical framework linking kinase selectivity, endothelial phenotypes, and the VEGFC–macrophage axis in hepatic fibrosis research.

• KN-62: Designing Causal Calcium Signaling Assays

  2026-09-02

  KN-62 is a selective CaMKII inhibitor for separating kinase-dependent signaling from direct calcium-channel effects. This guide builds a causal assay framework from neuronal channel pharmacology, with practical guidance for secretion, metabolism, and cell-cycle studies.

• E-64 for Cysteine Protease Assays

  2026-09-01

  E-64 provides irreversible, nanomolar-range cysteine protease inhibition for enzyme kinetics, lysate validation, and mechanism-focused cell studies. This guide shows how to use it as a biochemical control while avoiding common interpretation errors in cathepsin, calpain, and papain-like protease workflows.

• NP-40 Lysis Buffer for Translational Neuroimmunology

  2026-08-31

  A mechanistic and workflow-focused perspective on how non-denaturing protein extraction can strengthen FPR2/ALX, microglia, NK-cell, and SYK-AKT studies in autoimmune astrocytopathy.

• ConA Targets Conserved Coronavirus Spike Glycans

  2026-08-31

  This study identifies conserved high-mannose N-glycans near the coronavirus spike S2′ cleavage site as a broad-spectrum antiviral vulnerability. By combining fusion, pseudovirus, authentic infection, biochemical, and mouse experiments, the authors show that concanavalin A can block spike activation and reduce hCoV-NL63 disease in vivo.

• Difloxacin HCl: Assay Design Beyond MIC

  2026-08-30

  Difloxacin HCl supports both bacterial susceptibility studies and multidrug resistance reversal research. This article presents an assay-design framework that separates antibacterial phenotypes from transporter-related cellular effects and applies mechanistic lessons from mitotic checkpoint research.

• PA–Src–FAK–ROCK Signaling in Decidualization

  2026-08-29

  A 2025 FEBS Journal study identifies a phosphatidic acid–Src–FAK–RhoA/ROCK pathway that drives cytoskeletal remodeling during human endometrial stromal cell decidualization. Its key contribution is to distinguish morphology-linked signaling from canonical decidual markers and to connect the in vitro mechanism with uterine changes in ovariectomized mice.

8456 records 1/564 page Next 12345 下5页 Last page